Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Capital Expenditures (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Capital Expenditures for 4 consecutive years, with $320000.0 as the latest value for Q3 2025.

  • For Q3 2025, Capital Expenditures rose 100.59% year-over-year to $320000.0; the TTM value through Dec 2025 reached $320000.0, down 98.4%, while the annual FY2025 figure was $320000.0, 98.4% down from the prior year.
  • Capital Expenditures was $320000.0 for Q3 2025 at Day One Biopharmaceuticals, up from -$317000.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $55.0 million in Q2 2024, with the low at -$54.2 million in Q3 2024.
  • Historically, Capital Expenditures has averaged $1.5 million across 4 years, with a median of $26000.0 in 2022.
  • Biggest YoY gain for Capital Expenditures was 240525.0% in 2024; the steepest drop was 132417.07% in 2024.
  • Over 4 years, Capital Expenditures stood at $26000.0 in 2022, then tumbled by 69.23% to $8000.0 in 2023, then soared by 240525.0% to $19.2 million in 2024, then crashed by 98.34% to $320000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $320000.0 in Q3 2025, -$317000.0 in Q2 2025, and $317000.0 in Q1 2025.